Market Size of Canada Insulin Delivery Devices Industry
| Study Period | 2018 - 2028 |
| Base Year For Estimation | 2021 |
| Forecast Data Period | 2023 - 2028 |
| Market Size (2023) | USD 1.24 Billion |
| Market Size (2028) | USD 1.44 Billion |
| CAGR (2023 - 2028) | 2.99 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Canada Insulin Delivery Devices Market Analysis
The Canada Insulin Delivery Devices Market size is expected to grow from USD 1.24 billion in 2023 to USD 1.44 billion by 2028, at a CAGR of 2.99% during the forecast period (2023-2028).
Diabetes is one of the top chronic and life-threatening diseases affecting Canadians. The negative effects of COVID-19 on people with diabetes have underscored the importance of diabetes management in the country in recent years. In Canada, about 0.32 million people were living with Type 1 diabetes in 2021 and used insulin devices frequently to survive. The incidence of diabetes is expected to further rise in the country, which is expected to increase the adoption of insulin delivery devices during the forecast period. However, significant challenges hinder the widespread adoption of insulin delivery devices in Canada. A significant proportion of Canadians are not undertaking diabetes treatments due to the high costs. Although several provincial governments offer reimbursement for insulin delivery devices, patients often face issues related to limited coverage or not meeting eligibility criteria for their provincial plans. These issues are expected to hinder the market's growth during the forecast period.
